American Heart Association Recognizes Health Technology Innovators at Scientific Sessions 2026
The American Heart Association (AHA) recognized two health technology companies, Vascudyne and MedRhythms, with top honors at its Health Tech Competition during Scientific Sessions 2026. Vascudyne, based in St. Paul, Minnesota, received the Best Science award for its bioengineered blood vessel technology. This innovation aims to provide alternatives to harvesting a patient's leg vein for coronary bypass surgery and to create grafts for children with congenital heart defects that can grow with them. MedRhythms, from Portland, Maine, secured the Best Business, Audience Choice, and Best Overall awards for its digital health and neurotherapeutics solution. This solution combines sensors, software, and music to help individuals improve walking and mobility after stroke or other neurological injuries. The competition saw a record number of submissions globally, with five finalists selected for their potential to advance cardiovascular and brain health.